Royalty Pharma plc
Sector
Location
Market Cap
USD 20.87 B
Share Price
USD 37.12
Avg Daily Volume
4,791,530
Change (1 day)
Change (1 year)
Change (YTD)
AbbVie Inc.
USD 189.31
ABBV
Roche Holding AG
USD 337.03
RO.SW
Novartis AG
USD 116.45
NOVN.SW
Novo Nordisk A/S
USD 49.56
NOVO-B.CO
AstraZeneca PLC
USD 152.16
AZN.L
Abbott Laboratories
USD 128.55
ABT
Merck & Co., Inc.
USD 81.75
MRK
Thermo Fisher Scientific Inc.
USD 477.28
TMO
Amgen Inc.
USD 301.37
AMGN
Boston Scientific Corporation
USD 106.76
BSX
Gilead Sciences, Inc.
USD 114.76
GILD
Pfizer Inc.
USD 23.81
PFE
Sanofi
USD 97.52
SAN.PA
Vertex Pharmaceuticals Incorporated
USD 469.16
VRTX
Bristol-Myers Squibb Company
USD 45.98
BMY
Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
---|
AbbVie Inc.
USD 189.31
ABBV
Roche Holding AG
USD 337.03
RO.SW
Novartis AG
USD 116.45
NOVN.SW
Novo Nordisk A/S
USD 49.56
NOVO-B.CO
AstraZeneca PLC
USD 152.16
AZN.L
Abbott Laboratories
USD 128.55
ABT
Merck & Co., Inc.
USD 81.75
MRK
Thermo Fisher Scientific Inc.
USD 477.28
TMO
Amgen Inc.
USD 301.37
AMGN
Boston Scientific Corporation
USD 106.76
BSX
Gilead Sciences, Inc.
USD 114.76
GILD
Pfizer Inc.
USD 23.81
PFE
Sanofi
USD 97.52
SAN.PA
Vertex Pharmaceuticals Incorporated
USD 469.16
VRTX
Bristol-Myers Squibb Company
USD 45.98
BMY